Vincent Cálvez

18.0k total citations · 1 hit paper
408 papers, 11.2k citations indexed

About

Vincent Cálvez is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Vincent Cálvez has authored 408 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 320 papers in Infectious Diseases, 270 papers in Virology and 95 papers in Epidemiology. Recurrent topics in Vincent Cálvez's work include HIV Research and Treatment (270 papers), HIV/AIDS drug development and treatment (252 papers) and HIV/AIDS Research and Interventions (158 papers). Vincent Cálvez is often cited by papers focused on HIV Research and Treatment (270 papers), HIV/AIDS drug development and treatment (252 papers) and HIV/AIDS Research and Interventions (158 papers). Vincent Cálvez collaborates with scholars based in France, United States and Italy. Vincent Cálvez's co-authors include Anne‐Geneviève Marcelin, Christine Katlama, Roland Tubiana, Brigitte Autran, N. Dupin, Marc Wirden, Huldrych F. Günthard, Robert W. Shafer, Roger Paredes and Isabelle Malet and has published in prestigious journals such as The Lancet, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Vincent Cálvez

390 papers receiving 11.0k citations

Hit Papers

2015 update of the drug resistance mutations in HIV-1 2015 2026 2018 2022 2015 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Cálvez France 54 8.1k 7.3k 2.6k 1.4k 1.4k 408 11.2k
Anne‐Geneviève Marcelin France 49 6.3k 0.8× 5.3k 0.7× 2.0k 0.8× 1.2k 0.9× 1.3k 1.0× 364 8.8k
Robert T. Schooley United States 34 8.2k 1.0× 6.5k 0.9× 3.6k 1.4× 679 0.5× 682 0.5× 67 11.9k
Shinichi Oka Japan 45 4.3k 0.5× 3.2k 0.4× 2.8k 1.1× 1.0k 0.8× 610 0.4× 475 8.1k
Willy Rozenbaum France 43 5.0k 0.6× 5.8k 0.8× 3.1k 1.2× 1.2k 0.8× 1.1k 0.8× 169 11.0k
Joep M. A. Lange Netherlands 62 9.2k 1.1× 9.3k 1.3× 3.3k 1.3× 805 0.6× 721 0.5× 293 14.2k
Jan Gerstoft Denmark 48 4.8k 0.6× 3.6k 0.5× 3.0k 1.2× 623 0.5× 990 0.7× 303 9.2k
Jean‐Pierre Routy Canada 60 6.1k 0.8× 8.5k 1.2× 2.9k 1.1× 2.1k 1.5× 1.0k 0.8× 366 14.4k
José M. Gatell Spain 53 10.3k 1.3× 8.0k 1.1× 3.3k 1.3× 967 0.7× 461 0.3× 218 13.5k
Donna Mildvan United States 45 5.3k 0.7× 3.7k 0.5× 3.9k 1.5× 583 0.4× 526 0.4× 130 9.6k
Stéphane Blanche France 52 5.1k 0.6× 2.8k 0.4× 2.8k 1.1× 1.2k 0.8× 929 0.7× 254 9.6k

Countries citing papers authored by Vincent Cálvez

Since Specialization
Citations

This map shows the geographic impact of Vincent Cálvez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Cálvez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Cálvez more than expected).

Fields of papers citing papers by Vincent Cálvez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Cálvez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Cálvez. The network helps show where Vincent Cálvez may publish in the future.

Co-authorship network of co-authors of Vincent Cálvez

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Cálvez. A scholar is included among the top collaborators of Vincent Cálvez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Cálvez. Vincent Cálvez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wensing, Annemarie M. J., Charlotte Charpentier, Vincent Cálvez, et al.. (2025). Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance. Clinical Infectious Diseases. 81(4). e132–e136. 6 indexed citations
2.
Somboro, Anou M., Ibréhima Guindo, Djeneba Fofana, et al.. (2024). Dynamics of SARS-CoV-2 variants in West Africa: Insights into genomic surveillance in resource-constrained settings. Infection Genetics and Evolution. 125. 105681–105681. 1 indexed citations
4.
Marot, Stéphane, et al.. (2022). Human Herpesvirus 8 seroprevalence among blood donors in Mali. Journal of Medical Virology. 94(9). 4554–4558. 2 indexed citations
5.
Leducq, Valentin, P. Grange, Ousmane Faye, et al.. (2022). Primaquine as a Candidate for HHV-8-Associated Primary Effusion Lymphoma and Kaposi’s Sarcoma Treatment. Cancers. 14(3). 543–543. 2 indexed citations
6.
Jary, Aude, P. Grange, Valentin Leducq, et al.. (2022). Harnessing Redox Disruption to Treat Human Herpesvirus 8 (HHV-8) Related Malignancies. Antioxidants. 12(1). 84–84. 5 indexed citations
8.
Palich, Romain, Basma Abdi, Marc Wirden, et al.. (2021). Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients. Journal of Antimicrobial Chemotherapy. 76(7). 1893–1897. 1 indexed citations
9.
Palich, Romain, Elisa Teyssou, Sophie Sayon, et al.. (2021). Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected Patients. The Journal of Infectious Diseases. 225(3). 502–509. 12 indexed citations
10.
Cochet‐Escartin, Olivier, Philippe Gonzalo, Ivan Mikaélian, et al.. (2021). Hypoxia triggers collective aerotactic migration in Dictyostelium discoideum. eLife. 10. 23 indexed citations
11.
Jary, Aude, Valentin Leducq, Nathalie Désiré, et al.. (2020). New Kaposi’s sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies. The Journal of Infectious Diseases. 222(8). 1320–1328. 18 indexed citations
12.
Lambert-Niclot, Sidonie, Anders Boyd, Djeneba Fofana, et al.. (2019). INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels. Open Forum Infectious Diseases. 6(5). ofz177–ofz177. 7 indexed citations
13.
Lambert-Niclot, Sidonie, Jean‐Luc Meynard, Anne‐Geneviève Marcelin, et al.. (2018). Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Clinical Infectious Diseases. 67(12). 1883–1889. 3 indexed citations
14.
Wensing, Annemarie M. J., Vincent Cálvez, Huldrych F. Günthard, et al.. (2016). 2015 Update of the Drug Resistance Mutations in HIV-1.. PubMed. 23(4). 132–41. 56 indexed citations
15.
Wensing, Annemarie M. J., Vincent Cálvez, Huldrych F. Günthard, et al.. (2016). 2017 Update of the Drug Resistance Mutations in HIV-1.. PubMed. 24(4). 132–133. 149 indexed citations
16.
Fofana, Djeneba, Cathia Soulié, Almoustapha Issiaka Maïga, et al.. (2013). Genetic barrier to the development of resistance to rilpivirine and etravirine between HIV-1 subtypes CRF02_AG and B. Journal of Antimicrobial Chemotherapy. 68(11). 2515–2520. 6 indexed citations
17.
Todesco, Ève, Sophie Sayon, S. Fourati, et al.. (2013). Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies. Journal of Antimicrobial Chemotherapy. 68(12). 2882–2889. 3 indexed citations
18.
Grant, Philip, Jonathan Taylor, Andrew Nevins, et al.. (2010). International Cohort Analysis of the Antiviral Activities of Zidovudine and Tenofovir in the Presence of the K65R Mutation in Reverse Transcriptase. Antimicrobial Agents and Chemotherapy. 54(4). 1520–1525. 9 indexed citations
19.
Cálvez, Vincent, et al.. (2007). Résistance du VIH aux inhibiteurs d’entrée. Virologie. 11(2). 130–134.
20.
Amellal, Bahia, C. Rouzioux, S. Blanche, J.M. Huraux, & Vincent Cálvez. (2004). La toxicité mitochondriale des inhibiteurs nucléosidiques de la transcriptase inverse du VIH. Virologie. 8(4). 259–270.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026